NCT06128057

Brief Summary

Evaluate And Compare predictive value of TASH Score And MTBBS In need for Massive Blood Transfusion

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
22 days until next milestone

Study Start

First participant enrolled

December 5, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2025

Completed
Last Updated

November 13, 2023

Status Verified

November 1, 2023

Enrollment Period

1.6 years

First QC Date

October 26, 2023

Last Update Submit

November 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare predictive value of TASH Score And MTBBS In need for Massive Blood Transfusion

    Comparing odd number ( TASH score ) with even number (MTBSS ) in prediction for need for massive blood transfusion

    Baseline

Interventions

Massive blood transfusion

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Severe trauma patients

You may qualify if:

  • patients aged more than 18 years on both gender
  • ISS ≥ 16

You may not qualify if:

  • patients below 18 years
  • patients with known bleeding disorders such as hemophilia or von Willebrand disease
  • non trauma related bleeding : patients with severe hemorrhage unrelated to traumatic injury such as GI bleeding and ruptured aneurysm
  • transfer from other facilities if their initial trauma records and scoring data are not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Ogura T, Lefor AK, Masuda M, Kushimoto S. Modified traumatic bleeding severity score: early determination of the need for massive transfusion. Am J Emerg Med. 2016 Jun;34(6):1097-101. doi: 10.1016/j.ajem.2016.02.072. Epub 2016 Mar 3.

    PMID: 27021127BACKGROUND
  • Yucel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, Neugebauer EA, Wappler F, Bouillon B, Rixen D; Polytrauma Study Group of the German Trauma Society. Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma. 2006 Jun;60(6):1228-36; discussion 1236-7. doi: 10.1097/01.ta.0000220386.84012.bf.

    PMID: 16766965BACKGROUND
  • Tonglet ML. Early Prediction of Ongoing Hemorrhage in Severe Trauma: Presentation of the Existing Scoring Systems. Arch Trauma Res. 2016 Jun 20;5(4):e33377. doi: 10.5812/atr.33377. eCollection 2016 Dec.

    PMID: 28144603BACKGROUND
  • Bikbov B, Perico N, Remuzzi G. Mortality landscape in the global burden of diseases, injuries and risk factors study. Eur J Intern Med. 2014 Jan;25(1):1-5. doi: 10.1016/j.ejim.2013.09.002. Epub 2013 Sep 29.

    PMID: 24084027BACKGROUND
  • Mitra B, Cameron PA, Gruen RL, Mori A, Fitzgerald M, Street A. The definition of massive transfusion in trauma: a critical variable in examining evidence for resuscitation. Eur J Emerg Med. 2011 Jun;18(3):137-42. doi: 10.1097/MEJ.0b013e328342310e.

    PMID: 21164344BACKGROUND
  • Savage SA, Zarzaur BL, Croce MA, Fabian TC. Redefining massive transfusion when every second counts. J Trauma Acute Care Surg. 2013 Feb;74(2):396-400; discussion 400-2. doi: 10.1097/TA.0b013e31827a3639.

    PMID: 23354230BACKGROUND

Central Study Contacts

Abdelrhman Abouzeid

CONTACT

Esam eldeen Abdallah, professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

October 26, 2023

First Posted

November 13, 2023

Study Start

December 5, 2023

Primary Completion

July 5, 2025

Study Completion

November 10, 2025

Last Updated

November 13, 2023

Record last verified: 2023-11